About Ego Pharmaceuticals
Ego Pharmaceuticals is a Healthcare company based in Melbourne (Australia) founded in 1953 by Gerald Oppenheim. Skin pharmaceuticals are manufactured and distributed from Melbourne, Australia. Its chief executive, as recorded, is Alan Oppenheim. Its website egopharm.com draws about 60 thousand monthly visits. Ego Pharmaceuticals offers products and services including QV Skincare and SunSense. Its focus areas include Traditional Pharmaceuticals.
Company details
Ego Pharmaceuticals was established in 1953 in Melbourne, Australia, as a manufacturer in the pharmaceutical sector. Skin care treatments and related products are developed and produced at facilities in the region. Operations encompass formulation, quality control, and supply chain management for dermatological applications. The company is led by CEO Alan Oppenheim, with roots tracing to co-founder Gerald Oppenheim. Distribution occurs both domestically and internationally.
- Headquarters Melbourne, Australia
- Founders Gerald Oppenheim
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website egopharm.com/au/en.html
- Social LinkedIn X Facebook YouTube
- Legal Name Ego Pharmaceuticals
- Latest Funding Round$4.99M (USD), Debt – Conventional
Jul 2020
- Investors
Products & Services of Ego Pharmaceuticals
Ego Pharmaceuticals offers a comprehensive portfolio of products and services, including QV Skincare and SunSense.
Skincare products are developed for maintaining healthy skin, focusing on dermatological needs and backed by scientific research
Sunscreen products are formulated for skin protection against environmental factors, utilizing innovative manufacturing techniques
Apps and channels of Ego Pharmaceuticals
its YouTube channel Ego Pharmaceuticals has 677 subscribers and 30 videos.
Videos from Ego Pharmaceuticals
The most watched videos on Ego Pharmaceuticals's YouTube channel, Ego Pharmaceuticals (677 subscribers). Click a video to play it here.
More on Ego Pharmaceuticals.
Funding Insights of Ego Pharmaceuticals
- Total Rounds 1
- Last Round Debt – Conventional — $4.99M
- First Round $4.99M
(Jul 2020)
- Investors Count 1
All 1 funding rounds of Ego Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $4.99M | Debt – Conventional | – | – |
1 investors in total: 1 institutional.
Investors in Ego Pharmaceuticals
Ego Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Cheshire East Council.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Local government services are provided by Cheshire East Council. | cheshireeast.gov.uk | Crewe, United Kingdom |
Investor details for Ego Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ego Pharmaceuticals
37 people are tracked at Ego Pharmaceuticals (8 in leadership, 29 in team).
| Name | Role | Group |
|---|---|---|
Gerald Oppenheim | Co-Founder | Leadership |
Alan Oppenheim | CEO | Leadership |
Engy El Shamy | Finance & Complaince Head- Europe, Middle East & Africa | Leadership |
Glen Fleming | Chief Operating Officer | Leadership |
Fabrizio Spada Ph.d., Mraci Cchem | Chief Scientific And Innovation Officer | Leadership |
Jane Oppenheim | Scientific And Operations Director | Leadership |
Carol Gordon | EA To The Ceo/managing Director, Chief Commercial Officer And Board | Leadership |
Ron Chow | Head Of HK & Macau | General Managment | Leadership |
David K. | Northern Region Sales Manager | Team |
Holly Howard | Pharmacy Sales Representative | Team |
Dina Medhat | Medical Representative | Team |
Tim Hely-Hammond | Territory Manager | Team |
Bopha Kong | Quality Assurance Associate - Compliance | Team |
Amanda Foster-Brown | National Sales Manager UK | Team |
Amy McKeown | Commercial Manager UK | Team |
Jay Longden | GP Sales Rep | Team |
Tineke Woodroffe | QS Manager | Team |
Danish Deshmukh | Medical Representative | Team |
Tim Bailey | National Medical & B2b Manager | Team |
Ada Lui | Innovation & Development Researcher | Team |
17 more people are available in the full profile.
Complete people profiles for Ego Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ego Pharmaceuticals
2 dated milestones of Ego Pharmaceuticals across 67 years, from founding to its latest funding, stage changes and deals.
- Founded Ego Pharmaceuticals is founded.
- Funding First funding round of $5.0M.
Web traffic of Ego Pharmaceuticals
The website of Ego Pharmaceuticals (egopharm.com) receives about 60.5K visits a month.
- Monthly visits60.5K
▲ 20.5% vs previous month
Websites whose visitors overlap most with Ego Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
canesten.com.au | canesten.com.au | 100% | #585,576 | – | |
personalcaretruth.com | personalcaretruth.com | 84% | – | ||
pacificpharm.com.hk | pacificpharm.com.hk | 83% | #1,086,539 | – | |
| terrywhitechemmart.com.au | 83% | 648.1K | #74,421 | View details | |
| douglas.co.nz | 83% | 15.8K | #3,291,167 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Ego Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ego Pharmaceuticals
Ego Pharmaceuticals was founded in 1953 and raised its 1st funding round 67 years after it was founded.
Ego Pharmaceuticals is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
Alan Oppenheim is the CEO of Ego Pharmaceuticals, as recorded in our data.
Ego Pharmaceuticals was established in 1953 in Melbourne, Australia, as a manufacturer in the pharmaceutical sector. Skin care treatments and related products are developed and produced at facilities in the region. Operations encompass formulation, quality control, and supply chain management for dermatological applications. The company is led by CEO Alan Oppenheim, with roots tracing to co-founder Gerald Oppenheim. Distribution occurs both domestically and internationally.
Ego Pharmaceuticals offers QV Skincare and SunSense.
Ego Pharmaceuticals has 1 investor. Key investors include Cheshire East Council.
Ego Pharmaceuticals operates through Ego Pharmaceuticals.